Results 221 to 230 of about 426,371 (334)

A randomized neoadjuvant trial of anthracycline-taxane followed or not followed by cisplatin for HER-2 negative breast cancer

, 2017
S. Zhang, Yingjie Yuan, Tianqing Wang, Li Bian, Zefei Jiang   +4 more
openalex   +1 more source

Dacomitinib, a pan-inhibitor of ErbB receptors, suppresses growth and invasive capacity of chemoresistant ovarian carcinoma cells [PDF]

, 2017
et al,, Ghasemi, Reza
core   +2 more sources

Real‐Time, Label‐Free Classification of Cell Death Pathways via Holotomography‐Based Deep Learning Framework

Advanced Intelligent Systems, EarlyView.
A 3D holotomography system coupled with a deep learning model distinguishes how cells die—apoptosis, necroptosis or necrosis—without any fluorescent labels. Training on refractive index maps of HeLa cells yields 97% accuracy and flags necroptosis hours before chemical dyes.
Minwook Kim, Wei Sun Park, Geon Kim, Sanggeun Oh, Jaephil Do, Juyeon Park, Jihwan Yu, Won Do Heo, YongKeun Park   +8 more
wiley   +1 more source

CHEK2 loss endows chemotherapy resistance to hematopoietic stem cells. [PDF]

Leukemia
Zhou J, Hu T, Li D, Li S, Li M, Shi X, Nakada D.   +6 more
europepmc   +1 more source

PO-015 Potentiating anti-neoplastic effect of cisplatin by a protein arginine methyltransferase 5 selective inhibitor in lung adenocarcinoma cells

, 2018
Maha Saber-Ayad, Khuloud Bajbouj, Rakhee K. Ramakrishnan, Ahmed M.H.Ihmaid, Suhib AlHaj Ali, Abdulla Alalool, Reem Abdullah, Qutayba Hamid   +7 more
openalex   +1 more source

Extramedullary Disease—Achilles Heel in Myeloma?

American Journal of Hematology, EarlyView.
ABSTRACT Despite advances in therapy, extramedullary disease (EMD) remains an aggressive form of multiple myeloma associated with poor outcomes. Patients with true EMD, in which plasmacytomas have become completely independent of bone, have a particularly poor prognosis. The pathogenesis of EMD is driven by complex mechanisms involving loss of adhesion
Shaji Kumar, Joshua Richter, Saad Z. Usmani, Yael C. Cohen, Jing Christine Ye, María‐Victoria Mateos, Vania Hungria, Elena Zamagni   +7 more
wiley   +1 more source

Integrative Evaluation of <i>Kigelia africana</i> Fruit Extract: Broad-Spectrum Anticancer Activity, Synergism with Cisplatin and Mechanistic Insights in Colorectal Carcinoma. [PDF]

Molecules
Mihaylova R, Bebrivenski N, Zheleva-Dimitrova D, Simeonova R, Singh N, Konstantinov S, Momekov G.   +6 more
europepmc   +1 more source

A Prospective Multicenter Phase II Study of Cisplatin and Weekly Docetaxel as First-Line Treatment of Recurrent or Metastatic NAsopharyngeal Cancer (KCSG HN07-01)

, 2012
Junqiao Ji
openalex   +1 more source

The Nephroprotective Effect of Mannitol in Head and Neck Cancer Patients Receiving Cisplatin Therapy [PDF]

, 2019
Erik Hägerström, Lotte Lindberg, Jens Bentzen, Kasper Brødbæk, Bo Zerahn, Bent Bruun Kristensen   +5 more
openalex   +1 more source

Implantable Drug Delivery Systems for Skeletal Muscles and Eyes

Advanced NanoBiomed Research, EarlyView.
This review highlights the different types of recent implantable drug delivery systems (IDDS) fabricated for a use with skeletal muscles, and with eyes. It presents the developments already made and the current research directions, showing the evolution of IDDS and their great diversity.
Serge Ostrovidov, Murugan Ramalingam, Hongkai Wu, Toshinori Fujie, Yukinari Nakamura, Takeshi Hori, Yuji Nashimoto, Xuetao Shi, Hirokazu Kaji   +8 more
wiley   +1 more source